Corynebacterium glutamicum Mutant for High-Yield Glutamic Acid
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for producing L-glutamic acid by fermentation are not cost-effective enough to meet increasing demand, despite improvements in productivity, and there is a need for a more efficient process that enhances yield without increasing biomass.
Innovation Solution
A mutant strain of Corynebacterium glutamicum KFCC-11074 is developed by knocking out the cg2624 and/or cg2115 genes, allowing for improved glycerol utilization and increased L-glutamic acid production, with strains KCCM-10784P and KCCM-10785P exhibiting enhanced productivity and resistance to kanamycin and chloramphenicol, respectively.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If conventional fermentation methods are used to produce L-glutamic acid, then production capacity is maintained, but productivity and cost-effectiveness are insufficient to meet increasing demand
Solution Approach 1:
The invention changes the genetic parameters of the microorganism by knocking out specific genes (cg2624 and cg2115) to alter metabolic pathways. This genetic modification enables the strain to convert glycerol more efficiently into L-glutamic acid, achieving higher productivity without proportionally increasing production costs, thus resolving the contradiction between productivity and cost-effectiveness
Solution Approach 2:
The invention uses a mutant strain that replicates and maintains the desired metabolic characteristics across generations. The knockout mutant strain consistently produces higher yields of L-glutamic acid from glycerol, providing a stable, copyable solution that improves both productivity and cost-effectiveness through reliable genetic inheritance
2Quantity of substance
If biomass is increased to meet higher production demand, then total output capacity increases, but production cost and process complexity increase
Solution Approach 1:
The invention changes the metabolic parameters of the microorganism through gene knockout, enabling more efficient conversion of glycerol to L-glutamic acid. This metabolic reprogramming allows the strain to achieve higher product yield per unit of biomass, increasing total output without requiring proportional increases in biomass that would complicate the production process
Solution Approach 2:
The mutant strain autonomously performs the metabolic conversion of glycerol to L-glutamic acid with improved efficiency. The genetic modification enables the organism to self-optimize its metabolic pathways, producing higher yields without requiring external intervention or complex process controls, thereby reducing process complexity while increasing output
3Productivity
If glycerol utilization is improved through gene knockout, then L-glutamic acid production efficiency increases, but strain stability and adaptability may be affected
Solution Approach 1:
The invention creates a stable genetic copy of the desired knockout phenotype. By permanently removing the cg2624 and cg2115 genes from the genome, the strain reliably maintains improved glycerol utilization efficiency across generations. This genetic copying ensures both high productivity and strain stability, as the modified metabolic pathway is faithfully replicated in all descendant cells
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The mutant strains show a 20% to 37% increase in L-glutamic acid yield compared to the parental strain, demonstrating improved productivity while maintaining or reducing biomass levels, thus addressing the need for a more efficient production process.
Implementation Method 1
L-glutamic acid has been widely used in pharmaceuticals, food, animal feedstuffs, and other products. L-glutamic acid has conventionally been produced by fermentation mainly using so-called coryneform L-glutamic acid-producing bacteria
Data Source
AI summary
Disclosed herein are mutant strains, KCCM-10784P and KCCM-10785P, which are obtained through gene manipulation of Corynebacterium glutamicum KFCC-11074, and a process of producing L-glutamic acid using the mutant strains. The mutant strains are capable of producing L-Glutamic acid at high yield.